BKM Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$343K Sell
2,854
-310
-10% -$35.8K 0.13% 119
2025
Q4
$333K Sell
3,164
-118
-4% -$11.1K 0.12% 118
2025
Q3
$275K Sell
3,282
-254
-7% -$20.9K 0.1% 134
2025
Q2
$280K Sell
3,536
-356
-9% -$28.3K 0.11% 130
2025
Q1
$349K Sell
3,892
-23
-0.6% -$2.15K 0.14% 120
2024
Q4
$389K Buy
3,915
+404
+12% +$41.6K 0.16% 118
2024
Q3
$399K Sell
3,511
-5,889
-63% -$700K 0.16% 123
2024
Q2
$442K Buy
9,400
+5,281
+128% +$680K 0.21% 113
2024
Q1
$544K Buy
4,119
+915
+29% +$113K 0.23% 101
2023
Q4
$349K Buy
+3,204
New +$333K 0.15% 120

Other funds holding MRK

BKM Wealth Management's MRK Position: Q1 2026 in Review

BKM Wealth Management reduced its Merck (MRK) stake by 9.8% in Q1 2026, selling an estimated $35.8K and leaving 2,854 shares worth $343K. The position accounts for 0.13% of the portfolio, ranked #119.

BKM Wealth Management first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $544K in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • BKM Wealth Management held 2,854 shares of Merck worth $343K as of Q1 2026.
  • BKM Wealth Management sold 310 Merck shares in Q1 2026, an estimated $35.8K.
  • Merck made up 0.13% of BKM Wealth Management's portfolio in Q1 2026, its #119 holding.
  • BKM Wealth Management first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • BKM Wealth Management's Merck position peaked at $544K in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on BKM Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.